drugset / Trial / NCT04147260

Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin

NCT04147260

Phase 1 Completed 85 enrolled Boehringer Ingelheim
RandomizedParallel-groupSingle-blindTreatment

Summary

To evaluate the photosensitivity potential of BI 730357

Timeline

Start
2019-11-06
Primary completion
2020-09-09
Completion
2020-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 730357 Unknown
Comparator Ciprofloxacin Small molecule

Indications

No indication recorded.